U.S. Opportunities Fund
U.S. Opportunities Fund - Institutional USD Acc (VANGUOD)
Related Documents
About this fund
Fund objectives
- The Fund seeks to provide long-term capital growth.
- The Fund employs an “active management” strategy to invest mainly in U.S. stocks, with an emphasis on companies that are considered to have prospects for rapid earnings growth. The Fund’s Sub-Investment Manager, PRIMECAP Management Company (“PRIMECAP”), uses fundamental research to identify stocks that are expected to outperform the market over a three to five-year time horizon and that are available at attractive prices relative to their fundamental values. The Fund has the flexibility to invest in companies of any size, but it mostly invests in small and mid-cap stocks.
- The Fund may measure performance against the Russell 3000 Index (the “Index”), a market-capitalisation-weighted stock market index, composed of the top 3,000 US publically traded companies, as ranked by market capitalisation, or the total dollar value of all outstanding shares. The Fund is not otherwise constrained by or managed with reference to the Index. The Index does not define the investment universe of the Fund and the composition of the Fund may deviate significantly from that of the Index.
- The Fund’s policy is to remain substantially invested in common stocks that are listed or traded on exchanges or markets in the United States.
Fund facts
Share class inception
08 Apr 2002
Minimum initial investment
$5,000,000.00
Investment structure
Irish UCITS
Share Class Assets'
Total Assets
Strategy
Active
Asset Class
Equity
Domicile
Ireland
Dividend schedule
—
Legal entity
Vanguard Investment Series PLC
Benchmark
Russell 3000 Index
Register countries
Germany, Liechtenstein, Norway, Luxembourg, Finland, Italy, Denmark, Portugal, United Kingdom, Sweden, Austria, Ireland, Spain, France, Netherlands and Switzerland
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Performance
Risk and Volatility
As at 30 Sep 2026
Beta
R²
Annualized Tracking Error
1 year
3 years
5 years
Portfolio data
Characteristics
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 211 | 2,996 | 30 Sep 2026 |
| Median market capital | 38.1 B | 370.4 B | 30 Sep 2026 |
| 24.0 x | 24.0 x | 30 Sep 2026 | |
| 4.7 x | 4.8 x | 30 Sep 2026 | |
| 13.1% | 26.3% | 30 Sep 2026 | |
| 19.3% | 23.5% | 30 Sep 2026 | |
| Portfolio turnover rate | 5.4% | — | 30 Sep 2026 |
Market allocation
As at 30 Sep 2026
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| United States of America | North America | 93.00% | 99.36% | -6.36% |
| China | Emerging Markets | 3.40% | — | — |
| United Kingdom | Europe | 1.47% | — | — |
| Canada | North America | 1.04% | — | — |
| Germany | Europe | 0.35% | — | — |
| Sweden | Europe | 0.31% | 0.12% | 0.19% |
| Switzerland | Europe | 0.21% | — | — |
| France | Europe | 0.13% | — | — |
| Japan | Pacific | 0.10% | — | — |
| Peru | Emerging Markets | 0.00% | 0.03% | -0.03% |
| Panama | Emerging Markets | 0.00% | 0.00% | 0.00% |
| Other | Other | 0.00% | 0.40% | -0.40% |
| Israel | Middle East | 0.00% | 0.00% | 0.00% |
| Brazil | Emerging Markets | 0.00% | 0.09% | -0.09% |
| Singapore | Pacific | 0.00% | 0.00% | 0.00% |
Holdings details
As at 30 Sep 2026
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| Micron Technology Inc | 9.58126% | Information Technology | US | $136,376,684.40 | 128,040 |
| Xometry Inc | 5.05424% | Industrials | US | $71,940,489.50 | 699,470 |
| Eli Lilly & Co | 3.92338% | Health Care | US | $55,844,152.04 | 48,263 |
| Flex Ltd | 3.89030% | Information Technology | US | $55,373,365.60 | 503,440 |
| Intel Corp | 3.01046% | Information Technology | US | $42,849,972.00 | 356,400 |
| GRAIL Inc | 2.50050% | Health Care | US | $35,591,320.72 | 254,006 |
| Alphabet Inc | 2.17079% | Communication Services | US | $30,898,384.00 | 89,800 |
| BeOne Medicines Ltd | 1.84424% | Health Care | US | $26,250,339.96 | 71,734 |
| Glaukos Corp | 1.70411% | Health Care | US | $24,255,788.70 | 147,730 |
| Nextpower Inc | 1.66731% | Industrials | US | $23,731,944.97 | 304,529 |
Prices and distribution
Prices
NAV Price (USD)
$2,577.94
USDChange
+$11.180.44% At closure 29 Oct 2026
NAV 52-week high
$2,722.64
At closure 30 Oct 2026
NAV 52-week low
$1,904.69
At closure 30 Oct 2026
NAV 52-week difference
$817.95
Change
+30.04% At closure 30 Oct 2026
Historical Prices
-
Inception date
08 Apr 2002
| Date | NAV (USD) |
|---|---|
| 29 Oct 2026 | $2,577.9385 |
| 28 Oct 2026 | $2,566.7593 |
| 27 Oct 2026 | $2,527.5106 |
| 26 Oct 2026 | $2,474.7579 |
| 23 Oct 2026 | $2,445.8226 |
| 22 Oct 2026 | $2,449.6499 |
| 21 Oct 2026 | $2,491.8424 |
| 20 Oct 2026 | $2,481.4790 |
| 19 Oct 2026 | $2,454.3540 |
| 16 Oct 2026 | $2,441.0796 |
Purchase information
Currency
Base currency:USD
Fund codes
- Bloomberg:VANGUOD
- Citi:VA72
- ISIN:IE00B03HCY54
- MEX ID:VIUO
- SEDOL:B03HCY5